IMCD to acquire South Korean based Whawon Pharm Co. Ltd.
November 04, 2019 at 12:00 pm
Share
ROTTERDAM, The Netherlands (November 4, 2019) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and food ingredients, today announces that it signed an agreement to acquire 57% of the outstanding shares of South Korean based pharmaceutical ingredient distributor Whawon Pharm Co. Ltd. (“Whawon”).
Initially, IMCD will acquire 57% of the total share capital from the existing Whawon management, who will continue to lead the company. The remaining 43%, will be maintained by the management, for a period up to 5 years after closing.
Attachment
PRESS RELEASE _IMCD to acquire South Korean based Whawon Pharm Co. Ltd.
IMCD N.V. is one of the world's leaders in the distribution of specialty chemicals and food ingredients. The group's activity is organized primarily around 8 markets:
- house cleaning and maintenance products and textile products: surfactants, abrasives, bleaching agents, dyes, solubilizing agents, functional additives, etc.;
- pharmaceutical products: excipients, active pharmaceutical ingredients, solvents, formulation intermediates and chemical synthesis, etc.;
- personal care products: dyes, rheology modifiers, active and functional and sensory ingredients, sunscreen agents, antioxidants, exfoliants, preservatives, etc.;
- coating products: additives, pigments, resins and special solvents;
- nutritional and food products: acids, emulsifiers, oils, fibers, preservatives, sweeteners, enzymes, plant extracts, etc.;
- lubricants: additives, silicone derivatives, esters, corrosion inhibitors, markers, surfactants, etc.;
- chemical products synthesis: monomers, catalysts, reactive diluents, solvents and additives;
- plastic products: mixers, thermoplastic elastomers, polyurethanes, composite materials, etc.
Net sales break down geographically as follows: the Netherlands (1.5%), Europe/Middle East/Africa (42.2%), Asia/Pacific (24.5%), North America (22.3%), and Latin America (9.5%).